SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-112423
Filing Date
2012-03-13
Accepted
2012-03-13 17:29:50
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d289754d10k.htm 10-K 1170992
2 FOURTH AMENDMENT TO THE CREDIT AGREEMENT d289754dex105.htm EX-10.5 121439
3 LIST OF SUBSIDIARIES d289754dex21.htm EX-21 29352
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d289754dex23.htm EX-23 2921
5 RULE 13A-14(A) CERTIFICATION OF THE CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OF d289754dex311.htm EX-31.1 9252
6 RULE 13A-14(A) CERTIFICATION OF THE CHIEF FINANCIAL OFFICER OF THE COMPANY d289754dex312.htm EX-31.2 9246
7 SECTION 1350 CERTIFICATION OF CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER d289754dex321.htm EX-32.1 3777
8 SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE COMPANY d289754dex322.htm EX-32.2 3755
  Complete submission text file 0001193125-12-112423.txt   4077462

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT achc-20111231.xml EX-101.INS 522138
10 XBRL TAXONOMY EXTENSION SCHEMA achc-20111231.xsd EX-101.SCH 14225
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achc-20111231_cal.xml EX-101.CAL 44873
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achc-20111231_def.xml EX-101.DEF 14287
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE achc-20111231_lab.xml EX-101.LAB 179142
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achc-20111231_pre.xml EX-101.PRE 118896
Mailing Address 725 COOL SPRINGS BOULEVARD SUITE 600 FRANKLIN TN 37067
Business Address 725 COOL SPRINGS BOULEVARD SUITE 600 FRANKLIN TN 37067 615-732-6259
Acadia Healthcare Company, Inc. (Filer) CIK: 0001520697 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35331 | Film No.: 12688105
SIC: 8093 Services-Specialty Outpatient Facilities, NEC
Office of Life Sciences